Cargando…
Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania
BACKGROUND: Artemisinin-based combination treatment (ACT) has been widely adopted as one of the main malaria control strategies. However, its promise to save thousands of lives in sub-Saharan Africa depends on how effective the use of ACT is within the routine health system. The INESS platform evalu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651283/ https://www.ncbi.nlm.nih.gov/pubmed/23651521 http://dx.doi.org/10.1186/1475-2875-12-155 |
_version_ | 1782269195781668864 |
---|---|
author | Khatib, Rashid A Selemani, Majige Mrisho, Gumi A Masanja, Irene M Amuri, Mbaraka Njozi, Mustafa H Kajungu, Dan Kuepfer, Irene Abdulla, Salim M de Savigny, Don |
author_facet | Khatib, Rashid A Selemani, Majige Mrisho, Gumi A Masanja, Irene M Amuri, Mbaraka Njozi, Mustafa H Kajungu, Dan Kuepfer, Irene Abdulla, Salim M de Savigny, Don |
author_sort | Khatib, Rashid A |
collection | PubMed |
description | BACKGROUND: Artemisinin-based combination treatment (ACT) has been widely adopted as one of the main malaria control strategies. However, its promise to save thousands of lives in sub-Saharan Africa depends on how effective the use of ACT is within the routine health system. The INESS platform evaluated effective coverage of ACT in several African countries. Timely access within 24 hours to an authorized ACT outlet is one of the determinants of effective coverage and was assessed for artemether-lumefantrine (Alu), in two district health systems in rural Tanzania. METHODS: From October 2009 to June 2011we conducted continuous rolling household surveys in the Kilombero-Ulanga and the Rufiji Health and Demographic Surveillance Sites (HDSS). Surveys were linked to the routine HDSS update rounds. Members of randomly pre-selected households that had experienced a fever episode in the previous two weeks were eligible for a structured interview. Data on individual treatment seeking, access to treatment, timing, source of treatment and household costs per episode were collected. Data are presented on timely access from a total of 2,112 interviews in relation to demographics, seasonality, and socio economic status. RESULTS: In Kilombero-Ulanga, 41.8% (CI: 36.6–45.1) and in Rufiji 36.8% (33.7–40.1) of fever cases had access to an authorized ACT provider within 24 hours of fever onset. In neither of the HDSS site was age, sex, socio-economic status or seasonality of malaria found to be significantly correlated with timely access. CONCLUSION: Timely access to authorized ACT providers is below 50% despite interventions intended to improve access such as social marketing and accreditation of private dispensing outlets. To improve prompt diagnosis and treatment, access remains a major bottle neck and new more innovative interventions are needed to raise effective coverage of malaria treatment in Tanzania. |
format | Online Article Text |
id | pubmed-3651283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36512832013-05-11 Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania Khatib, Rashid A Selemani, Majige Mrisho, Gumi A Masanja, Irene M Amuri, Mbaraka Njozi, Mustafa H Kajungu, Dan Kuepfer, Irene Abdulla, Salim M de Savigny, Don Malar J Research BACKGROUND: Artemisinin-based combination treatment (ACT) has been widely adopted as one of the main malaria control strategies. However, its promise to save thousands of lives in sub-Saharan Africa depends on how effective the use of ACT is within the routine health system. The INESS platform evaluated effective coverage of ACT in several African countries. Timely access within 24 hours to an authorized ACT outlet is one of the determinants of effective coverage and was assessed for artemether-lumefantrine (Alu), in two district health systems in rural Tanzania. METHODS: From October 2009 to June 2011we conducted continuous rolling household surveys in the Kilombero-Ulanga and the Rufiji Health and Demographic Surveillance Sites (HDSS). Surveys were linked to the routine HDSS update rounds. Members of randomly pre-selected households that had experienced a fever episode in the previous two weeks were eligible for a structured interview. Data on individual treatment seeking, access to treatment, timing, source of treatment and household costs per episode were collected. Data are presented on timely access from a total of 2,112 interviews in relation to demographics, seasonality, and socio economic status. RESULTS: In Kilombero-Ulanga, 41.8% (CI: 36.6–45.1) and in Rufiji 36.8% (33.7–40.1) of fever cases had access to an authorized ACT provider within 24 hours of fever onset. In neither of the HDSS site was age, sex, socio-economic status or seasonality of malaria found to be significantly correlated with timely access. CONCLUSION: Timely access to authorized ACT providers is below 50% despite interventions intended to improve access such as social marketing and accreditation of private dispensing outlets. To improve prompt diagnosis and treatment, access remains a major bottle neck and new more innovative interventions are needed to raise effective coverage of malaria treatment in Tanzania. BioMed Central 2013-05-07 /pmc/articles/PMC3651283/ /pubmed/23651521 http://dx.doi.org/10.1186/1475-2875-12-155 Text en Copyright © 2013 Khatib et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Khatib, Rashid A Selemani, Majige Mrisho, Gumi A Masanja, Irene M Amuri, Mbaraka Njozi, Mustafa H Kajungu, Dan Kuepfer, Irene Abdulla, Salim M de Savigny, Don Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title | Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title_full | Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title_fullStr | Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title_full_unstemmed | Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title_short | Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania |
title_sort | access to artemisinin-based anti-malarial treatment and its related factors in rural tanzania |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651283/ https://www.ncbi.nlm.nih.gov/pubmed/23651521 http://dx.doi.org/10.1186/1475-2875-12-155 |
work_keys_str_mv | AT khatibrashida accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT selemanimajige accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT mrishogumia accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT masanjairenem accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT amurimbaraka accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT njozimustafah accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT kajungudan accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT kuepferirene accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT abdullasalimm accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania AT desavignydon accesstoartemisininbasedantimalarialtreatmentanditsrelatedfactorsinruraltanzania |